C12Y 305/04005
Cytidine deaminase
Official title: Cytidine deaminase (3.5.4.5)
C12Y305/04005 (Cytidine deaminase) appears on 85 US grants and 268 published applications in this corpus.
Search patents in C12Y- Granted patents
- 85
- Published applications
- 268
- Assignees
- 106
- Inventors
- 542
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 2 |
| 2010 | 1 | 1 |
| 2011 | 1 | 1 |
| 2012 | 1 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 3 | 9 |
| 2016 | 0 | 1 |
| 2017 | 2 | 3 |
| 2018 | 1 | 6 |
| 2019 | 3 | 13 |
| 2020 | 3 | 17 |
| 2021 | 6 | 22 |
| 2022 | 8 | 40 |
| 2023 | 11 | 29 |
| 2024 | 14 | 47 |
| 2025 | 17 | 35 |
| 2026 | 14 | 37 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for increasing mutation introduction efficiency in genome sequence modification technique, and molecular complex to be used therefor25 Aug 2026US 12,716,076 B2National University Corporation Kobe University
- CRISPR-aid using catalytically inactive RNA-guided endonuclease30 Jun 2026US 12,668,819 B2Novozymes A/S
- Systems, methods, and compositions for targeted nucleic acid editing16 Jun 2026US 12,655,403 B2
- Compositions, methods, and systems for genome editing technology9 Jun 2026US 12,649,917 B2North Carolina State University
- Fusion proteins for DNA base editing12 May 2026US 12,624,361 B2Syngenta Crop Protection AG
- Cas-embedded Cytidine Deaminase Ribonucleoprotein Complexes having Improved Base Editing Specificity and Efficiency8 Oct 2026US 2026/0308553 A1University of Massachusetts
- Single base editing of atnx2 for the treatment of sca217 Sep 2026US 2026/0273101 A1The Children’s Hospital of Philadelphia
- Multi-site editing in living cells10 Sep 2026US 2026/0265731 A1President and Fellows of Harvard College
- Compositions and methods for altering complement activation3 Sep 2026US 2026/0258407 A1Beam Therapeutics Inc.
- Compositions and Methods for Analyzing Modified Nucleotides3 Sep 2026US 2026/0258479 A1New England Biolabs, Inc.
Most cited
By later US patents
- Methods for correcting presenilin point mutations123US 9,068,179 B1President and Fellows of Harvard College · 2015
- Methods for nucleic acid editing121US 9,840,699 B2President and Fellows of Harvard College · 2017
- Nucleobase editors and uses thereof90US 10,167,457 B2President and Fellows of Harvard College · 2019
- Fusions of Cas9 domains and nucleic acid-editing domains74US 11,053,481 B2President and Fellows of Harvard College · 2021
- Cas variants for gene editing73US 11,124,782 B2President and Fellows of Harvard College · 2021